Progyny, Inc. (PGNY)

NASDAQ: PGNY · IEX Real-Time Price · USD
32.32
+1.03 (3.29%)
Mar 31, 2023, 12:27 PM EDT - Market open
3.29%
Market Cap 3.02B
Revenue (ttm) 786.91M
Net Income (ttm) 30.36M
Shares Out 93.38M
EPS (ttm) 0.30
PE Ratio 108.17
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 631,456
Open 31.71
Previous Close 31.29
Day's Range 31.12 - 32.69
52-Week Range 25.67 - 53.10
Beta 1.55
Analysts Buy
Price Target 45.08 (+39.48%)
Earnings Date May 3, 2023

About PGNY

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimburseme... [Read more]

Sector Healthcare
IPO Date Oct 25, 2019
Employees 311
Stock Exchange NASDAQ
Ticker Symbol PGNY
Full Company Profile

Financial Performance

In 2022, Progyny's revenue was $786.91 million, an increase of 57.19% compared to the previous year's $500.62 million. Earnings were $30.36 million, a decrease of -53.84%.

Financial Statements

Analyst Forecast

According to 12 analysts, the average rating for PGNY stock is "Buy." The 12-month stock price forecast is $45.08, which is an increase of 39.48% from the latest price.

Price Target
$45.08
(39.48% upside)
Analyst Consensus: Buy
Stock Forecasts

News

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation - PGNY

NEW YORK , March 31, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Progyny, Inc. (NASDA...

12 hours ago - PRNewsWire

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation - PGNY

NEW YORK , March 31, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Progyny, Inc. (NASDA...

12 hours ago - PRNewsWire

Children's Hospital Association Selects Progyny as Exclusive Partner for Fertility and Family Building Benefits

As the vendor of choice, Progyny's comprehensive benefit with proven clinical outcomes will be recommended to the more than 220 children's hospitals in the CHA network As the vendor of choice, Progyny...

1 week ago - GlobeNewsWire

Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum

NEW YORK, March 20, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that ...

1 week ago - GlobeNewsWire

Progyny Enhances Male Fertility Offering with the Expansion of its Reproductive Urologist Network

NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) a leading benefits management company specializing in fertility and family building benefits solutions, today announced the ex...

2 weeks ago - GlobeNewsWire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation - PGNY

NEW YORK , March 3, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Progyny, Inc. (NASDAQ...

3 weeks ago - PRNewsWire

A Barron's Portfolio of Stocks Outperformed This Week. Alcoa, Progyny and Other Stocks That Popped.

The Barron's portfolio dropped 1.2% in the past five days, compared with a 1.77% dip in the S&P 500 stock index.

Other symbols: AA
1 month ago - Barrons

NATIONALLY RANKED ROSEN LAW FIRM Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation – PGNY

NEW YORK--(BUSINESS WIRE)---- $PGNY #PGNY--WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Progyny, Inc. (NASD...

1 month ago - Business Wire

Progyny (PGNY) Q4 Earnings and Revenues Beat Estimates

Progyny (PGNY) delivered earnings and revenue surprises of 50% and 1.47%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Progyny, Inc. Announces Fourth Quarter 2022 Results

Reports Full Year Revenue of $786.9 Million, Reflecting 57% GrowthReports Record Quarterly Revenue and Operating Cash Flow of $214.3 Million and $51.5 Million, RespectivelyIssues Financial Guidance fo...

1 month ago - GlobeNewsWire

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation - PGNY

NEW YORK , Feb. 24, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Progyny, Inc. (NASDAQ...

1 month ago - PRNewsWire

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation - PGNY

NEW YORK , Feb. 17, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Progyny, Inc. (NASDAQ...

1 month ago - PRNewsWire

ROSEN, A Leading Law Firm, Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation - PGNY

New York, New York--(Newsfile Corp. - February 16, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Pro...

1 month ago - Newsfile Corp

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2022 Results Report

NEW YORK, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financ...

1 month ago - GlobeNewsWire

SHAREHOLDER ALERT: Investigation of Progyny, Inc. (PGNY) Announced by Nationally Ranked Investors' Rights Firm Holzer & Holzer, LLC

Atlanta, Georgia--(Newsfile Corp. - February 7, 2023) - Holzer & Holzer, LLC is investigating whether Progyny, Inc. ("Progyny" or the "Company") (NASDAQ: PGNY) complied with federal securities laws. O...

1 month ago - Newsfile Corp

Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on Progyny, Inc. (Nasdaq: PGNY)

Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on Progyny, Inc. (Nasdaq: PGNY)

1 month ago - Business Wire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY

NEW YORK , Feb. 7, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ: PGNY). Such investors are advised to contact...

1 month ago - PRNewsWire

Will Progyny (PGNY) Beat Estimates Again in Its Next Earnings Report?

Progyny (PGNY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

2 months ago - Zacks Investment Research

In Search of an Earnings Beat? Play These Top 5 Stocks

These top-ranked stocks are likely to beat on bottom line in their next releases. Tap Yum China (YUMC), Impinj (PI), Five Below (FIVE), Hologic (HOLX) and Progyny (PGNY).

Other symbols: FIVEHOLXPIYUMC
2 months ago - Zacks Investment Research

7 Stocks With a Forward P/E of 25 to Run Away From

With a rough 2022 spilling into 2023, we're running into a broad list of stocks to avoid. Especially those in the tech space, where high-profile layoffs have picked up amid a severe slowdown in growth...

2 months ago - InvestorPlace

Progyny to Discuss its Strong 2022 Financial Performance at Upcoming Investor Conference

Anticipates Results to be at the High-End of its Previously Provided Financial GuidanceAnticipates Reporting Record Fourth Quarter Operating Cash Flow of Approximately $50 Million

2 months ago - GlobeNewsWire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Progyny, Inc. - PGNY

New York, New York--(Newsfile Corp. - December 17, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ: PGNY). Such investors are...

3 months ago - Newsfile Corp

ELV vs. PGNY: Which Stock Is the Better Value Option?

ELV vs. PGNY: Which Stock Is the Better Value Option?

Other symbols: ELV
3 months ago - Zacks Investment Research

Looking for Earnings Beat? Buy These 5 Stocks With Potential

These top-ranked stocks -- Chewy (CHWY), Progyny (PGNY), KnowBe4 (KNBE), Chegg (CHGG) and Fortinet (FTNT) -- are likely to beat on their bottom line in the next releases.

Other symbols: CHGGCHWYFTNT
3 months ago - Zacks Investment Research

PGNY EQUITY NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation - PGNY

NEW YORK , Dec. 15, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Progyny, Inc. (N...

3 months ago - PRNewsWire